在POU2F-POU2AF转录因子驱动的恶性瘤中准mSWI/SNF复合体
Tongchen He1,2,3,4, Lanbo Xiao1,2,4, Yuanyuan Qiao1,2,5
1Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
小细胞肺癌亚型SCLC-P和某些B细胞恶性瘤依赖于mSWI/SNF复合体. 用PROTAC降解剂准这个复合体在临床前模型中显示出治疗前景.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 染色体生物学 染色体生物学
背景情况:
- POU2F3转录因子复合体调节了状细胞发育和状细胞类小细胞肺癌 (SCLC).
- POU2F3驱动的癌症,特别是SCLC-P,显示出对哺乳动物开关/非发酵糖 (mSWI/SNF) 染色质重塑复合物的独特依赖.
研究的目的:
- 为了研究POU2F驱动的恶性瘤对哺乳动物开关/非发酵糖 (mSWI/SNF) 染色质重塑复合物的依赖.
- 评估针对SCLC和B细胞恶性瘤中mSWI/SNF复合物的治疗潜力.
主要方法:
- 使用蛋白质分解向嵌合体 (PROTAC) 降解剂以向mSWI/SNF复合体的ATPase亚单元.
- 评估SCLC细胞系和临床前模型对mSWI/SNF ATPase降解的敏感性.
- 研究了分子机制,包括染色质可访问性和转录因子驱逐.
- 在SCLC和多发性髓瘤的小鼠模型中评估了疗效和毒性.
主要成果:
- POU2F3驱动的SCLC-P细胞对mSWI/SNF ATPase降解表现出极高的敏感性.
- 一种新的PROTAC降解剂,AU-24118,选择性地准SCLC-P,并减少瘤生长,毒性最小.
- 包括多发性骨髓瘤在内的POU2F1/2驱动的B细胞恶性瘤也对mSWI/SNF ATPase降解敏感.
- 在多发性骨髓瘤模型中,AU-24118在玛利多米德上显示出更高的生存益处.
结论:
- 由POU2F-POU2AF驱动的癌症,包括SCLC-P和某些B细胞恶性瘤,对mSWI/SNF染色体重塑复合物具有可利用的依赖性.
- mSWI/SNF ATPase降解代表了这些恶性瘤的有前途的治疗策略,AU-24118显示出显著的临床前疗效和有利的安全性.
更多相关视频
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
相关概念视频
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
